NCT05948410

Brief Summary

The goal of this study is to learn about the patient's perspective regarding to psychological mood before and after an invasive urodynamic study.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 17, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

July 17, 2023

Status Verified

July 1, 2023

Enrollment Period

1 year

First QC Date

July 9, 2023

Last Update Submit

July 9, 2023

Conditions

Keywords

invasive urodynamic studymood

Outcome Measures

Primary Outcomes (3)

  • The State-Trait Anxiety Inventory (STAI)

    Questionnaire

    1 week

  • Visual Analogue Scale

    Questionnaire

    1 week

  • Perceived Stress Scale

    Questionnaire

    1 week

Study Arms (1)

Study Group

Patients with an indication of invasive urodynamic study

Behavioral: The State-Trait Anxiety Inventory (STAI)Behavioral: Perceived Stress ScaleBehavioral: Visual Analog Scale

Interventions

The State-Trait Anxiety Inventory (STAI) is a psychological inventory consisting of 40 self-report items on a 4-point Likert scale. The STAI measures two types of anxiety - state anxiety and trait anxiety. Higher scores are positively correlated with higher levels of anxiety.

Study Group

The Perceived Stress Scale (PSS) is the most widely used psychological instrument for measuring the perception of stress. It is a measure of the degree to which situations in one's life are appraised as stressful. Items were designed to tap how unpredictable, uncontrollable, and overloaded respondents find their lives. The scale also includes a number of direct queries about current levels of experienced stress. PSS scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 \& 4 = 0) to the four positively stated items (items 4, 5, 7, \& 8) and then summing across all scale items. A short 4 item scale can be made from questions 2, 4, 5 and 10 of the PSS 10 item scale

Study Group

The visual analogue scale (VAS) is a psychometric response scale that can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end points.

Study Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with an indication of invasive urodynamic study

You may qualify if:

  • Patients with an invasive urodynamic study indication

You may not qualify if:

  • Non-Turkish speakers
  • Poor conscious state

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Lower Urinary Tract SymptomsDisease

Interventions

Perceived Stress Scale

Condition Hierarchy (Ancestors)

Urological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Central Study Contacts

Tufan Tarcan, Prof

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

July 9, 2023

First Posted

July 17, 2023

Study Start

October 1, 2023

Primary Completion

October 1, 2024

Study Completion

January 1, 2025

Last Updated

July 17, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share